Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr-Jun;15(2):196-198.
doi: 10.4103/JCAS.JCAS_145_21.

Imprint Cytology Can Be a Better Option for Diagnosis of Mammary Paget's Disease!!!: A Case Report with Review

Affiliations
Case Reports

Imprint Cytology Can Be a Better Option for Diagnosis of Mammary Paget's Disease!!!: A Case Report with Review

Pranita Mohanty et al. J Cutan Aesthet Surg. 2022 Apr-Jun.

Abstract

Mammary Paget's disease (MPD) is a rare form of pruritic eczematous skin lesion involving the nipple areola complex usually associated with an underlying in-situ or invasive carcinoma of breast, accounting ≤ 4% of overall breast carcinoma. The patient may present with nipple discharge, eczema, plaque, or nipple destruction with or without a lump which is resistant to common remedies. Diagnosis of MPD is usually accomplished by a punch biopsy, but imprint cytology is found to be an effective modern technique yet less explored. Cytological diagnosis is advantageous over surgical excisional biopsy; advantages being easy practicability, cost-effective, quick non-invasive, and above all can lead the physician for breast-preserving surgeries in selective cases rather than more aggressive standard mastectomies. We report one such case of MPD in a 52-year-old female diagnosed on imprint cytology with the aim to emphasize that imprint cytology can be a better option to improve the treatment protocol.

Keywords: Breast-conserving surgery; imprint cytology; mammary Paget.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(A and B) Cytology showing Paget’s cells in an inflammatory background (Diff Quik, ×100). (C-E) Photomicrograph showing large polygonal to round Paget’s cells with hyperchromatic nuclei (H&E, ×400)
Figure 2
Figure 2
(A) PAS is negative in tumor cells (PAS, ×100). (B-D) Immunohistochemistry showing strong membranous positivity for CK7, EMA, and Her-2-neu, respectively (IHC, ×400)

Similar articles

References

    1. Valdes EK, Feldman SM. Paget’s disease of the breast. Breast J. 2006;12:83. - PubMed
    1. Dixon AR, Galea MH, Ellis IO, Elston CW, Blamey RW. Paget’s disease of the nipple. Br J Surg. 1991;78:722–3. - PubMed
    1. Paget J. On disease of the mammary areola preceding cancer of the mammary gland. St Bartholomew’s Hosp Rep. 1874;10:87–9.
    1. Sakorafas GH, Blanchard K, Sarr MG, Farley DR. Paget’s disease of the breast. Cancer Treat Rev. 2001;27:9–18. - PubMed
    1. Lloyd J, Flanagan AM. Mammary and extramammary Paget’s disease. J Clin Pathol. 2000;53:742–9. - PMC - PubMed

Publication types